Exhaled nitric oxide, serum ECP and airway responsiveness in mild asthmatic children

European Respiratory Journal

Volumn 15, Issue 5, 2000, Pages 839-843

  Piacentini, G L ^a   Bodini, A ^a   Costella, S ^b   Suzuki, Y ^a   Zerman, L ^a   Peterson, C G B ^c   Boner, A L ^a,d  

^a UNIVERSITY OF VERONA   (Italy)

^b Istituto Pio XII   (Italy)

^c PFIZER INC   (United States)

^d POLICLINICO BORGO ROMA   (Italy)

Author keywords

Airway inflammation; Airway responsiveness; Childhood asthma; Markers of airway inflammation; Nitric oxide; Serum eosinophil cationic protein

Indexed keywords

BECLOMETASONE; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE; METHACHOLINE; NITRIC OXIDE; STEROID;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXPIRED AIR; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION TEST; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; STEROID THERAPY;

EID: 0034067344     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15e05.x     Document Type: Article

References (43)

1. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137: 62-69.
2. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407-1413.
3. Kirby JG, Hargreave FE, Gleich GJ, O'Byrne PM. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987; 136: 379-383.
4. Bentley AM, Menz G, Storz D, et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma: relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis 1992; 146: 500-506.
5. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cell and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88: 935-942.
6. Bradley BL, Azzawi M, Jacobson M, et al. Eosinophils, T-lymphocytes, mast cell, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88: 661-674.
7. Ollerenshaw SL, Woolcock AJ. Characteristics of the inflammation in biopsies from large airway of subjects with asthma and subjects with chronic airflow limitation. Am Rev Respir Dis 1992; 145: 922-927.
8. Djukanovic R, Wilson JW, Britten KM, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990; 142: 863-871.
9. Ferguson AC, Wong FW. Bronchial hyperresponsiveness in asthmatic children: correlation with macrophages and eosinophils in broncholavage fluid. Chest 1989; 96: 988-991.
10. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140: 1745-1753.
11. Adelroth E, Rosenhall L, Johansson SA, Linden M, Venge P. Inflammatory cell and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage: the effects of antiasthmatic treatment with budesonide or terbutalide. Am Rev Respir Dis 1990; 142: 91-99.
12. Ferdousi HA, Dreborg S. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity. Clin Exp Allergy 1997; 27: 530-539.
13. Ferguson AC, Vaughan R, Brown H, Curtis C. Evaluation of serum eosinophil cationic protein as a marker of disease activity in chronic asthma. J Allergy Clin Immunol 1995; 95: 23-28.
14. Ruse GC, Andersson B, Ahlstedt S. Bronchial brush biopsies for studies of epithelial inflammation in stable asthma and nonobstructive chronic bronchitis. Eur Respir J 1996; 9: 1665-1671.
15. Hoekstra MO, Hovenga H, Gerritsen J, Kauffman HF. Eosinophils and eosinophil-derived protein in children with moderate asthma. Eur Respir J 1996; 9: 2231-2235.
16. Kharitonov SA, Barnes PJ. Exhaled nitric oxide: a marker of inflammation? Curr Opin Anaesthesiol 1996; 9: 542-548.
17. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368-1370.
18. Artlich A, Hagenah JU, Jonas S, Ahrens P, Gortner L. Exhaled nitric oxide in childhood asthma. Eur J Pediatr 1996; 155: 698-701.
19. Kharitonov SA, Yates DH, Chung KF, Barnes PJ. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996; 9: 196-201.
20. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153: 454-457.
21. Baraldi E, Azzolin NM, Zanconato S, Dario C, Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr 1997; 131: 381-386.
22. Garnier P, Fajac I, Dessanges JF, Dall'Ava-Santucci J, Lockhart A, Dinh-Xuan AT. Exhaled nitric oxide during acute changes of airways calibre in asthma. Eur Respir J 1996; 9: 1134-1138.
23. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53: 91-95.
24. Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998; 157: 894-898.
25. Jatakanon A, Lim S, John M, et al. Effect of inhaled budesonide on lung function and airway inflammation: assessmant by various inflammatory markers in mild asthma. Am J Respir Crit Care Med 1999; 159: 22-30.
26. Piacentini GL, Martinati L, Fornari A, et al. Antigen avoidance in a mountain environment: influence on basophil releasability in children with allergic asthma. J Allergy Clin Immunol 1993; 92: 644-650.
27. Hargreave FE, Ryan G, Thomson NC. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981; 68: 347-355.
28. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness. Standardized challenge testing with pharmacolological, physical and sensitizing stimuli in adults. Report of the Working Party Standardization of Lung Function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 53-83.
29. Barnes PJ, Kharitonov SA. Exhaled nitric oxide: a new lung function test. Thorax 1996; 51: 233-237.
30. Kharitonov SA, Chung KF, Evans D, O'Connor BJ, Barnes PJ. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996; 153: 1773-1780.
31. Kharitonov SA, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J 1997; 10: 1683-1693.
32. Lundberg JON, Weitzberg E, Lundberg JM, Alving K. Nitric oxide in exhaled air. Eur Respir J 1996; 9: 2671-2680.
33. Byrnes CA, Dinarevic S, Shinebourne EA, Barnes PJ, Bush A. Exhaled nitric oxide measurements in normal and asthmatic children. Pediatr Pulmonol 1997; 24: 312-318.
34. van der Mark ThW, Kort E, Meijer RJ, Postma DS, Koeter GH. Water vapour and carbon dioxide decrease nitric oxide readings. Eur Respir J 1997; 10: 2120-2123.
35. Van Schayck CP, Graafsma SJ, Visch MB, Dompeling E, van Weel C, van Herwaarden CLA. Increased bronchial hyperresponsiveness after inhaling salbutamol during I year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol 1990; 86: 793-800.
36. Fernivik E, Gronneberg R, Lundahl J. The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of patients with mild asthma. Allergy 1996; 51: 697-705.
37. Hansel TT, Braunstein JB, Walker C. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 1991; 86: 271-277.
38. Kips JC, Pauwels RA. Serum eosinophil cationic protein in asthma: what does it mean? Clin Exp Allergy 1998; 28: 1-3.
39. Haley KJ, Drazen JM. Inflammation and airway function in asthma. Am J Respir Crit Care Med 1998; 157: 1-3.
40. ten Hacken NHT, Meijer RJ, Kerstjens HAM, van der Mark ThW. Expired Nitric Oxide in Stable Asthmatic Patients does not Relate to Parameter of Disease Severity. Eur Respir J 1996; 9: Suppl. 23, 416s.
41. Taylor DA, Lim S, Barnes PJ, O'Connor BJ. Exhaled Nitric Oxide Production and Increased Airway Responsiveness in Asthma Reflect Different Inflammatory Pathways. Eur Respir J 1996; 9: Suppl. 23, 416s-417s.
42. Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 1995; 9: 416S.
43. Leusink-Muis A, Ten Broeke R, Folkerst G, De Clerck F, Nijkamp FP. Beclomethasone prevents virus-induced airway inflammation but not airway hyperresponsiveness in guinea pigs. Clin Exp Allergy 1999; 29(Suppl. 2): 82-85.